PALM BEACH, Florida, March 28, 2017 /PRNewswire/ --
MarketNewsUpdates.com News Commentary
Cannabinoidsand CBD Extracts continue to be a strong focal point for cannabis operators as revenues climb higher behind a robust jump in sales volume. Many industry professionals expect CBD infused lifestyle products could be the next big Cannabis maketplace. Cannabis
PotNetwork Holding, Inc. (OTC: POTN) announced today that upon starting 2017 with the advantageous acquisition of Diamond CBD, Inc. and the Company's transition back into the cannabis, hemp and related markets, coupled with Diamond CBD's robust sales pipeline, the Company is projected to generate over $1,700,000.00 in gross revenues during the first quarter of 2017 alone.
Regarding developments, Maria Gomez, Regional Vice President of Sales, Diamond CBD, stated: "As the Marijuana sector continues to expand, so has our corporate vision and drive for brand distinction and differentiation. For Diamond CBD, sales have accelerated from $1,663,081.78 for the 4 quarters of 2016 to a pace that will probably exceed $1,700,000.00 for the 1st quarter of 2017, meaning that we've established significant momentum for the remainder of this year. Even if sales only remain consistent, it would represent a revenue increase in the range of almost 400% percent, year-over-year." Read this and more news for POTN at http://marketnewsupdates.com/news/potn.html
In accordance with the Company's aggressive branding and marketing strategy, its subsidiary, Diamond CBD, Inc., exhibited at ASD Market Week, in Las Vegas, NV, an international event known to showcase the world's widest variety of popular retail merchandise in a one-stop shopping experience. ASD Market Week boasts 45,000 buyers from 88 countries annually. Ninety-eight percent of these attendees have major purchasing power with the average buyer spending $82,500.00 per show, equating to $2.8 billion annually.
In other sector developments:
Cannabis Science, Inc(OTC: CBIS), a U.S. company specializing in the development of cannabis-based medicines, announced late yesterday that it has substantially increased its production for its self-medicating patient product line distributed through cannabis dispensaries in California. CBIS moves to meet the outstanding influx of self-medicating patient requests as it highlights Moonlight Cannabis as its Newest Spotlight Dispensary for the Month of April 2017. "Moonlight Cannabis has now received most of Cannabis Sciences' newest developed products. We have just received the newest batch of our CBIS MDI Inhaler just in time for this spotlight announcement and look forward to feedback from customers of Moonlight Cannabis about this new product.
Medical Marijuana, Inc. (OTC: MJNA) announced yesterday that its subsidiary, Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has unveiled a renewed line of chewable energy supplements meant to enhance and energize an on-the-go lifestyle. This is yet another premium product added to its growing line of lifestyle products. Kannaway Energy Chews are a bite-sized line of hemp-based energy supplements with 5mg of CBD derived from sustainable hemp oil and vitamin B, meant to support cognitive function, mood and energy levels. The Company sees Kannaway Energy Chews as an affordable, healthy and natural alternative to junk food, energy drinks, and pricey coffee.
Acology Inc. (OTC: ACOL) closed up slightly on Monday trading over 8.1 Million shares by the market close. Executives of Acology Inc. (ACOL), in response to investor inquiries about the company's multinational expansion, have expressed confidence that the anticipated legalization of recreational cannabis in Canada will produce growth and strong, sustained retail and wholesale business. With the Canadian National Government, led by strong, pro-cannabist Prime Minister Justin Trudeau, ready to ask for legalization in the next few weeks and the high likelihood of the referendum passing, companies that have anticipated legalization are in a good position to benefit from the new law.
MyDx, Inc. (OTCQB: MYDX) closed up over 23% on Monday trading over 126.2 Million shares by the market close. MyDx, a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for the Cannabis professional and retail consumer to correlate the chemical profile of cannabis with how it makes consumers feel and what it helps them relieve, just over a week ago announced the successful resolution of the contentious relationship with the company and its toxic convertible debenture lenders. The Company took an aggressive stance in early March, filing for a temporary restraining order when it believed that it had fully satisfied its obligations to certain notes on its balance sheet, yet continued to receive conversion notices to payoff balances that were claimed outstanding.
DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated nine thousand nine hundred dollars for news coverage of the current and future press release sissued by PotNetwork Holding, Inc. by a non-affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.
Contact Information: Media Contact email: firstname.lastname@example.org - +1(561)325-8757
Subscribe to our Free Newsletters!
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...
Video-electroencephalography monitoring is a diagnostic technique that records the electrical ...
Myomectomy is a surgery that is done to remove fibroids, which are non-cancerous growths of the ...View All